Skip to main content
Aleksandra Rachitskaya, MD, Ophthalmology, Cleveland, OH

AleksandraRachitskayaMD

Ophthalmology Cleveland, OH

Retinal Disease

Physician

Dr. Rachitskaya is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Rachitskaya's full profile

Already have an account?

  • Office

    9500 Euclid Ave
    Cleveland, OH 44195
    Phone+1 216-445-9519
    Fax+1 216-445-2226

Education & Training

  • B Palmer Eye Institute - A B Leach Eye
    B Palmer Eye Institute - A B Leach EyeChief Residency, Chief Resident & Co-Director of Ocular Trauma, 2013 - 2014
  • University of Miami Hospital and Clinics
    University of Miami Hospital and ClinicsFellowship, Surgical Retina and Vitreous, 2012 - 2014
  • University of Miami/Jackson Health System/Bascom Palmer Eye Institute
    University of Miami/Jackson Health System/Bascom Palmer Eye InstituteResidency, Ophthalmology, 2009 - 2012
  • George Washington University
    George Washington UniversityResidency, Internal Medicine, 2008 - 2009
  • Case Western Reserve University School of Medicine
    Case Western Reserve University School of MedicineClass of 2008

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2014 - 2026
  • FL State Medical License
    FL State Medical License 2012 - 2022
  • DC State Medical License
    DC State Medical License 2008 - 2009
  • VA State Medical License
    VA State Medical License 2008 - 2009
  • American Board of Ophthalmology Ophthalmology

Clinical Trials

Publications & Presentations

PubMed

Authored Content

  • Invasive Eye Operations Should Be Left up to Surgeons. Ohio Bill a Dangerous to Your SightJune 2024
  • Argus II Retinal Prosthesis Complication Profile Pre- and Post-FDA ApprovalAugust 2018

Press Mentions

  • The Port Delivery System Shows Long-Term Potential for Multiple Diseases
    The Port Delivery System Shows Long-Term Potential for Multiple DiseasesJuly 30th, 2024
  • Cole Eye Patients Taking GLP-1 Receptor Agonists for Diabetes Did Not Have Worsening Retinopathy
    Cole Eye Patients Taking GLP-1 Receptor Agonists for Diabetes Did Not Have Worsening RetinopathyJune 26th, 2024
  • Diabetic Retinopathy Incidence, Progression May Be Lower in Native Americans
    Diabetic Retinopathy Incidence, Progression May Be Lower in Native AmericansMarch 10th, 2023
  • Join now to see all

Other Languages

  • Russian